Nephrotic syndrome with sunitinib-associated focal segmental glomerulosclerosis in a patient with renal carcinoma: partial reversibility after dose adjustment: Case Report. (2025). Revista De La Sociedad Ecuatoriana De Nefrología, Diálisis Y Trasplante, 13(2), 149-156. https://doi.org/10.56867/118